Clusterin CSF levels in differential diagnosis of neurodegenerative disorders
Objective: To find a specific in vivo marker to improve a differential diagnosis between Parkinson´s disease and atypical Parkinsonian syndromes, especially early in the course…Monoaminergic biomarkers of cognitive decline in Parkinson’s disease and Lewy body dementia
Objective: The objective of this study was the identification of biochemical markers of cognitive impairment in Parkinson's disease (PD) and dementia with Lewy bodies (DLB)…
- « Previous Page
- 1
- …
- 21
- 22
- 23